DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats ENA Respiratory has been awarded ...
Tag: Thermostability
U.S. Delivers Additional Vaccines and Freezer Trucks to Bangladesh for COVID Vaccination Efforts
The U.S. Donates Another 10 Million Pfizer Vaccines to Bangladesh; U.S.-Donated Doses Now Exceed 38 Million The U.S. donated an ...
DTRA Works to Create Freeze-Dried Portable Biomanufacturing for Nimble Response to Emerging Biothreats
Advancements in biomanufacturing are bringing on-demand, shelf-stable vaccines to the front lines. By the year 2050, it is estimated that ...
Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 – and ...
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic
Just like a fresh piece of fish, vaccines are highly perishable products and must be kept at very cold, specific ...
The Challenge of Vaccine Cold Chain Logistics: How a Chemical ‘Casing’ Could Save Lives
Amid unpredictable outbreaks, and fears of a second wave, the hunt is on for a vaccine against COVID-19. The reason ...
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing
Bavarian Nordic A/S announced on Jan. 18 that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised another ...
Soligenix Receives Japanese Patent for Vaccine Heat Stabilization Technology
Soligenix, Inc. announced today that it has been granted a Japanese patent (number 6110845) further extending protection around ThermoVax including ...
Positive Preliminary Results for Thermostable Ebola Vaccine
Soligenix, Inc. this week announced positive preliminary proof-of-concept results from its collaboration with University of Hawaiʻi at Mānoa (UH Mānoa) ...
Soligenix Wins Additional 4.3M to Advance Ricin Vaccine Manufacturing
Soligenix, Inc. today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised an option for RiVax™ ...
BARDA Issues 3 New Broad Agency Announcements for Biodefense
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in ...
NIAID Exercises Option on Thermostable Ricin Vaccine Contract
Soligenix, Inc. today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to advance ...
RFI – Vaccine Candidates and Technologies for Filoviruses
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical and biopharmaceutical product developers on multivalent ...
Soligenix Mid-Year Report Strong for Biodefense Efforts
Soligenix, Inc., a late-stage biopharmaceutical company developing products in the areas of biodefense, inflammation, and oncology, today announced highlights and ...
NIH, CDC Seek Small Business R&D Proposals
The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are soliciting research and development ...
Second Partner Backs UH Effort to Develop Thermostable Ebola Vaccine
Soligenix, Inc. last week announced a collaboration agreement with Axel Lehrer, PhD, of the UH Mānoa Department of Tropical Medicine, ...
Polio Vaccination with Microneedle Patches
The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda ...
BARDA Backs Emergent Biosolutions’ NuThrax Vaccine
Advanced development is underway on an improved anthrax vaccine that could provide protection in fewer doses than the currently licensed ...
HHS Accelerates Ebola Vaccines
Officials from the U.S. Department of Health and Human Services commented last week on the accelerated development of two promising ...
New 15-Minute Ebola Diagnostic to be Trialed in Guinea
A rapid, point-of-care diagnostic test for the Ebola virus will be trialed in the coming weeks at the Ebola treatment ...
